Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
HemoShear Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
HemoShear Therapeutics

HemoShear Therapeutics

US-based HemoShear Therapeutics innovates treatments for rare metabolic disorders.

HQ
Charlottesville, VA, US
Founded
2008
Overview
Compare
Fundraising
Employees
Website

Founded in Charlottesville, United States, HemoShear Therapeutics is dedicated to developing innovative treatments for patients with rare metabolic disorders. The company's core mission is to leverage advanced biological and computational models to gain deep insights into disease mechanisms, identify novel drug targets, and translate these discoveries into effective therapies. Central to their approach is the REVEAL-Tx™ drug discovery platform, which combines human disease models to drive the development of promising drug candidates.

HemoShear Therapeutics has garnered attention for its pioneering work in the field of rare metabolic disorders. Notable figures affiliated with the company include experts in biotechnology and pharmacology who have contributed significantly to its research and development efforts. The company has achieved key milestones in identifying and validating new drug targets, positioning itself as a leader in its niche market. Through its innovative platform and focused mission, HemoShear Therapeutics has made a substantial impact on the potential treatment landscape for rare metabolic diseases.

HemoShear Therapeutics - Similar Companies

Haima Therapeutics logo

Haima Therapeutics

ReviR Therapeutics logo

ReviR Therapeutics

revirtx.com

Blade Therapeutics logo

Blade Therapeutics

Empirico logo

Empirico

empiricotx.com

Unravel Biosciences logo

Unravel Biosciences

unravel.bio

Star Therapeutics logo

Star Therapeutics

ProFound Therapeutics logo

ProFound Therapeutics

profoundtx.com

Herophilus logo

Herophilus

herophilus.com

Astria Therapeutics logo

Astria Therapeutics

astriatx.com

Citrine Medicine logo

Citrine Medicine

Rezo Therapeutics logo

Rezo Therapeutics

rezotx.com

Rheos Medicines logo

Rheos Medicines

Elgia Therapeutics logo

Elgia Therapeutics

Reactive Biosciences logo

Reactive Biosciences

reactivebio.com

Theradaptive logo

Theradaptive

theradaptive.com

HemoShear Therapeutics - Quick Facts

Who are HemoShear Therapeutics' competitors?

Companies similar to HemoShear Therapeutics include Haima Therapeutics, ReviR Therapeutics, Blade Therapeutics and Empirico.

When was HemoShear Therapeutics founded?

HemoShear Therapeutics was founded in 2008.

Where is HemoShear Therapeutics' headquarters located?

HemoShear Therapeutics' headquarters is located in Charlottesville, VA, US.

When was HemoShear Therapeutics' last funding round?

HemoShear Therapeutics' most recent funding round was for $3.5M (USD) in November 2023.

How much has HemoShear Therapeutics raised to-date?

As of Nov 14, 2023, HemoShear Therapeutics has raised a total of $63.6M (USD).

How many employees does HemoShear Therapeutics have?

HemoShear Therapeutics has 56 employees as of Feb 5, 2024.

HemoShear Therapeutics - Classification

Ownership
  • Equity
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Drug Development
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 7210Research and experimental development on natural sciences and engineering
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
  • 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified